About Saguaro
Saguaro is a company based in Quebec City (Canada) founded in 2020 by Felix Lavoie Perusse and Louis Turcotte. Saguaro has raised $4.1 million across 2 funding rounds from investors including Frederic Ors, AQC Capital and Anges Québec. The company has 4 employees as of December 31, 2024. Saguaro offers products and services including ChromaLIVE, NucleoLIVE, and MortaLIVE. Saguaro operates in a competitive market with competitors including Cellply, Lucid Scientific, Kiyatec, CytoTronics and Remedy Plan, among others.
- Headquarter Quebec City, Canada
- Employees 4 as on 31 Dec, 2024
- Founders Felix Lavoie Perusse, Louis Turcotte
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$4.1 M (USD)
in 2 rounds
-
Latest Funding Round
$3 M (USD), Seed
Jun 04, 2024
-
Investors
AQC Capital
& 4 more
-
Employee Count
4
as on Dec 31, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Saguaro
Saguaro offers a comprehensive portfolio of products and services, including ChromaLIVE, NucleoLIVE, and MortaLIVE.
Non-toxic dye for real-time biological insights in live cells.
Tool for cell proliferation and nuclei labeling in research.
Assay for cell viability and cytotoxicity monitoring over time.
People of Saguaro
Unlock access to complete
Unlock access to complete
Leadership Team
2 people
Strategic Team
1 people
Advisor Team
1 people
Finance and Accounting
1 people
Unlock access to complete
Funding Insights of Saguaro
Saguaro has successfully raised a total of $4.1M across 2 strategic funding rounds. The most recent funding activity was a Seed round of $3 million completed in June 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Saguaro
Saguaro has secured backing from 5 investors, including angel, venture fund, and institutional investors. Prominent investors backing the company include Frederic Ors, AQC Capital and Anges Québec.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
-
|
Locked | Locked | Locked | |
|
Angel investment network supporting innovative entrepreneurs in Canada.
|
Locked | Locked | Locked | |
|
Business guidance for corporate companies and startups
|
Locked | Locked | Locked |
Investor details for Saguaro
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Saguaro
Investment portfolio details for Saguaro
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Saguaro
Detailed financials for Saguaro
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Saguaro Comparisons
Peer comparison for Saguaro
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Saguaro
Saguaro operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Cellply, Lucid Scientific, Kiyatec, CytoTronics and Remedy Plan, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Developer of in-vitro diagnostic products for the detection of cancer
|
|
| Locked | Locked | Locked |
Real-time cell analyzers are developed for oxygen consumption monitoring.
|
|
| Locked | Locked | Locked |
Kiyatec is focused on revolutionizing cancer care through predictive platforms.
|
|
| Locked | Locked | Locked |
Cell-based assays for drug discovery are developed via CMOS platform.
|
|
| Locked | Locked | Locked |
Metastatic cancer properties are targeted by Remedy Plan's containment therapy.
|
Detailed competitors of Saguaro
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Saguaro
Complete news archive for Saguaro
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Saguaro
Saguaro was founded in 2020 and raised its 1st funding round 2 years after it was founded.
Saguaro is headquartered in Quebec City, Canada. It is registered at Quebec City, Quebec, Canada.
Louis Turcotte is the current CEO of Saguaro. They have also founded this company.
Saguaro is a funded company, having raised a total of $4.1M across 2 funding rounds to date.
As of Dec 31, 2024, the latest employee count at Saguaro is 4.
Saguaro was founded in 2020 and is based in Quebec City, Canada. Operations focus on the biotechnology sector, where next-generation technologies for drug discovery and therapies are developed. The product line includes ChromaLive Non-Toxic Dyes, hydrogels for 3D cell cultures, and PrimaFeed defined culture medium. These tools support advanced research in cellular environments.
Saguaro's top competitors include CytoTronics, Kiyatec and Remedy Plan.
Saguaro offers ChromaLIVE, NucleoLIVE, and MortaLIVE.
Saguaro has 5 investors. Key investors include Frederic Ors, AQC Capital, Anges Québec, Martin Leblanc, and Invest Quebec.